Search results for: information research

This notice constitutes a combined synopsis and Broad Agency Announcement (BAA) for the acquisition of research and development (R&D) in accordance with Federal Acquisition Regulation 35.016, "Broad agency announcement," as supplemented with additional information included in this notice. No other solicitation will be issued. Only the information provided in this notice is available.

The University is seeking qualified contractors able to provide MilTech Information Research Services to support project deliverables. Interested vendors may submit a proposal to one or more of the six Service Categories in this RFP: Market & Competitor, Qualitative and/or Quantitative Primary Research, GIS Mapping, and Patent & Licensing Research.

Title: Technical Information Research Resources for Cancer Prevention Agent DevelopmentThe purpose of this acquisition is to provide a variety of information management functions necessary to support the identification, development, and qualification of potential cancer preventive agents for IND applications to the FDA for clinical trials.

A SOLICITATION WILL BE ISSUED ON A LATER DATE.Title: Technical Information Research Resources for Cancer Prevention Agent DevelopmentDescription:This is a re-competition of contract HHSN2612011000080C awarded to CCS Associates located at 2001 Gateway Place, 350W, San Jose, California, on September 30, 2011.

The Capability Statements will be evaluated based on the information provided in relation to the project requirements and the current capability to: 1) perform the work in the attached Draft Statement of Work; 2) staff education, training, experience, expertise and knowledge; 3) prior completed projects and Government contracts of a similar nature; 4) corporate experience and management; and 5) computing infrastructure.Information Submission Instructions

A one year cost plus fixed fee Contract (with four option years) for Technical Information Research Resources for Cancer Preventive Agent Development was awarded to CCS Associates on September 15, 2023 in the amount of $2,403,457.

The purpose of the acquisition is to provide a variety of critical cancer prevention information management functionsnecessary to support the identification, development, and qualification of potential cancer preventive agents forInvestigational New Drug (IND) applications to the Food and Drug Administration (FDA) for clinical trials.